NASDAQ:AVGR Avinger (AVGR) Stock Price, News & Analysis $1.42 -0.19 (-11.80%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.22▼$1.5050-Day Range$1.61▼$3.5852-Week Range$1.22▼$14.00Volume972,615 shsAverage Volume40,471 shsMarket Capitalization$2.41 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Avinger alerts: Email Address Avinger MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside252.1% Upside$5.00 Price TargetShort InterestHealthy2.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.08) to ($1.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.10 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAvinger has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAvinger has received no research coverage in the past 90 days.Read more about Avinger's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.47% of the float of Avinger has been sold short.Short Interest Ratio / Days to CoverAvinger has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avinger has recently decreased by 23.03%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvinger does not currently pay a dividend.Dividend GrowthAvinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVGR. Previous Next 3.3 News and Social Media Coverage News SentimentAvinger has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Avinger this week, compared to 0 articles on an average week.Search Interest1 people have searched for AVGR on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Avinger to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avinger insiders have not sold or bought any company stock.Percentage Held by Insiders11.40% of the stock of Avinger is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 18.30% of the stock of Avinger is held by institutions.Read more about Avinger's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Avinger are expected to grow in the coming year, from ($2.08) to ($1.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avinger is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avinger is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Avinger Stock (NASDAQ:AVGR)Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Read More AVGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVGR Stock News HeadlinesJuly 22, 2024 | americanbankingnews.comAvinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.comMay 17, 2024 | finance.yahoo.comAre Medical Stocks Lagging Avinger (AVGR) This Year?July 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.May 17, 2024 | finanznachrichten.deAvinger, Inc.: Avinger Announces Conversion of $11 Million of CRG Debt into Preferred EquityMay 16, 2024 | finance.yahoo.comAvinger Inc (AVGR) Q1 2024 Earnings Call Transcript Highlights: Strategic Partnerships and ...April 3, 2024 | msn.comAvinger files to sell 2.05M shares for holdersMarch 22, 2024 | seekingalpha.comAvinger, Inc. (AVGR) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | finance.yahoo.comAvinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call TranscriptJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.March 20, 2024 | investorplace.comAVGR Stock Earnings: Avinger Misses Revenue for Q4 2023March 12, 2024 | finance.yahoo.comAvinger to Announce Full Year 2023 Results on March 20, 2024March 11, 2024 | seekingalpha.comWeek In Review: EurekaBio Raises $40M To Support Lentiviral Vector PlatformMarch 7, 2024 | msn.comAvinger enters partnership with Zylox-Tonbridge, to get $15 million of equity fundingMarch 7, 2024 | prnewswire.comZylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular InterventionsMarch 6, 2024 | finanznachrichten.deAvinger, Inc.: Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-TonbridgeMarch 6, 2024 | stockhouse.comImportant Notice to Avinger Investors and Aegis Capital Customers: Please Contact the Law Firm of KlaymanToskesMarch 1, 2024 | yahoo.comUT Tyler to host free health screenings in Avinger on SaturdayFebruary 29, 2024 | edition.cnn.comAvinger, Inc.See More Headlines Receive AVGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:AVGR CUSIPN/A CIK1506928 Webwww.avinger.com Phone(650) 241-7900Fax800-229-2696Employees68Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+247.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($18.1856) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,320,000.00 Net Margins-251.78% Pretax Margin-251.78% Return on EquityN/A Return on Assets-117.36% Debt Debt-to-Equity RatioN/A Current Ratio0.70 Quick Ratio0.48 Sales & Book Value Annual Sales$7.65 million Price / Sales0.32 Cash FlowN/A Price / Cash FlowN/A Book Value($4.53) per share Price / Book-0.32Miscellaneous Outstanding Shares1,700,000Free Float1,508,000Market Cap$2.45 million OptionableNot Optionable Beta1.25 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jeffrey M. Soinski (Age 62)President, CEO & Director Comp: $616.79kMr. Nabeel P. Subainati (Age 40)VP of Finance, Principal Financial Officer & Accounting Officer Comp: $347.58kMr. Himanshu N. Patel (Age 64)Chief Technology Officer Comp: $430.08kMr. Keith SchaeferChief Operating OfficerMr. Philip R. Preuss (Age 46)Chief Marketing Officer & VP of Business Operations Mr. Corey GibbsVice President of SalesDr. Jaafer Golzar FACCM.D., Chief Medical OfficerMore ExecutivesKey CompetitorsPAVmedNASDAQ:PAVMPlus TherapeuticsNASDAQ:PSTVGlucoTrackNASDAQ:GCTKVivos TherapeuticsNASDAQ:VVOSNeuroMetrixNASDAQ:NUROView All Competitors AVGR Stock Analysis - Frequently Asked Questions How have AVGR shares performed this year? Avinger's stock was trading at $2.71 at the beginning of the year. Since then, AVGR shares have decreased by 47.6% and is now trading at $1.42. View the best growth stocks for 2024 here. How were Avinger's earnings last quarter? Avinger, Inc. (NASDAQ:AVGR) posted its earnings results on Wednesday, May, 15th. The medical device company reported ($2.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.35) by $1.14. The medical device company earned $1.86 million during the quarter, compared to the consensus estimate of $2.36 million. When did Avinger's stock split? Avinger's stock reverse split on the morning of Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Avinger IPO? Avinger (AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. How do I buy shares of Avinger? Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avinger investors own include Bionano Genomics (BNGO), Novan (NOVN), Titan Pharmaceuticals (TTNP), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Organigram (OGI) and Onconova Therapeutics (ONTX). This page (NASDAQ:AVGR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVGR Stock Alerts